ValGANciclovir 50 mg in 1 mL Oral Solution
RxNorm 863559
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 863559 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: valGANciclovir 50 mg in 1 mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Valganciclovir 50 mg/ML Oral Solution
(Atom ID: 2992814)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely valganciclovir (as valganciclovir hydrochloride) 50 mg/1 mL conventional release oral solution (clinical drug)
(Atom ID: 11440895)
SYPrescribable
Synonym (SY):
Valganciclovir (as valganciclovir hydrochloride) 50 mg/ML Oral Solution
(Atom ID: 9702156)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
ValGANciclovir (as valGANciclovir hydrochloride) 50 mg/ML Oral Solution
(Atom ID: 9702574)
PTPrescribable
Designated preferred name (PT):
Valganciclovir (as valganciclovir hydrochloride) 50 mg/mL oral solution
(Atom ID: 11441600)
PSNPrescribable
Prescribable Name (PSN):
ValGANciclovir 50 mg in 1 mL Oral Solution
(Atom ID: 8260764)
SYPrescribable
Synonym (SY):
Valganciclovir 50 mg per 1 mL Oral Solution
(Atom ID: 8260765)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
ValGANciclovir 50 mg per 1 mL Oral Solution
(Atom ID: 8261516)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
ValGANciclovir 50 mg/ML Oral Solution
(Atom ID: 3741557)
Patient Education
Valganciclovir
Valganciclovir is used to treat cytomegalovirus (CMV) retinitis (eye infection that can cause blindness) in people who have acquired immunodeficiency syndrome (AIDS). Valganciclovir is also used to prevent cytomegalovirus (CMV) disease in people who have received a heart, kidney, or kidney-pancreas transplant and who have a chance of getting CMV disease. Valganciclovir is in a class of medications called antivirals. It works by preventing the spread of CMV disease or slowing the growth of CMV.
[Learn More]
* Please review the disclaimer below.